As a leading provider of nitinol components and services, 91快活林 participated in the 2024 SMST conference. The program was heavily focused on the latest research and development in nitinol, with 91快活林 among other industry leaders presenting their work. Kevin Kelly, CEO of 91快活林, emphasized that this scientific focus is crucial for continuing to push the boundaries of what’s possible with nitinol, particularly in the growing medical device market.